Serum LD1 isoenzyme and blood lymphocyte subsets as prognostic indicators for severe acute respiratory syndrome

Journal of Internal Medicine

Volumn 255, Issue 4, 2004, Pages 512-518

  Chan, M H M ^a   Wong, V W S ^a   Wong, C K ^a   Chan, P K S ^a   Chu, C M ^b   Hui, D S C ^a   Suen, M W M ^c   Sung, J J Y ^a   Chung, S S C ^a   Lam, C W K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^c ALICE HO MIU LING NETHERSOLE HOSPITAL   (Hong Kong)

Author keywords

Lactate dehydrogenase isoenzyme; Lymphocyte subsets; Multiple ROC analysis; Pathophysiology; Prognosis; Severe acute respiratory syndrome (SARS)

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CEFOTAXIME; HEMOGLOBIN; HYDROCORTISONE; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE ISOENZYME; LEVOFLOXACIN; METHYLPREDNISOLONE; PREDNISOLONE; RIBAVIRIN; STEROID;

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CLINICAL PROTOCOL; CONFIDENCE INTERVAL; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HEMOGLOBIN DETERMINATION; HONG KONG; HOSPITAL ADMISSION; HUMAN; IMMUNOLOGICAL PARAMETERS; INTENSIVE CARE UNIT; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATURAL KILLER CELL; OUTCOMES RESEARCH; PARAMETER; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEVERE ACUTE RESPIRATORY SYNDROME; STEROID THERAPY; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD; ANTIMETABOLITES; AREA UNDER CURVE; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYDROCORTISONE; ISOENZYMES; L-LACTATE DEHYDROGENASE; LEUKOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; PREDNISOLONE; PROGNOSIS; RETROSPECTIVE STUDIES; RIBAVIRIN; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 11144357447     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2004.01323.x     Document Type: Article

References (27)

1. Peiris JSM, Lai ST, Poon LLM et al. Severe acute respiratory syndrome (SARS) is associated with a coronavirus. Lancet 2003; 361: 1319-25.
2. Lee N, Hui D, Wu A et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348: 1986-94.
3. Booth CM, Matukas LM, Tomlinson GA et al. Clinical features and short-term outcomes of 144 patients with SARS in the Greater Toronto Area. JAMA 2003; 289: 2801-9.
4. Anonymous. Outbreak of severe acute respiratory syndrome -worldwide. 2003. MMWR 2003; 52: 226-8.
5. World Health Organization. Severe acute respiratory syndrome (SARS) - multi-country outbreak - update 49. http:// www.who.int/csr/don/2003_05_07a/en/ (accessed 19 May 2003).
6. Cui W, Fan Y, Wu W et al. Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome. Clin Infect Dis 2003; 37: 857-9.
7. World Health Organization. Severe acute respiratory syndrome (SARS). Wkly Epidemiol Rec 2003; 78: 81-3.
8. Tomlinson B, Cockram C. SARS: experience at Prince of Wales Hospital. Hong Kong. Lancet 2003; 361: 486-7.
9. World Health Organization. PCR primers for SARS developed by WHO Network Laboratories. http://www.who.lnt/csr/sars/ primers/en/print/html (accessed 20 September 2003).
10. Wong GWK, Hui DSC. Severe acute respiratory syndrome (SARS): epidemiology, diagnosis and management. Thorax 2003; 58: 558-60.
11. Chan MHM, Chow KM, Chan ATC et al. Quantitative analysis of pleural fluid cell-free DNA as a tool for the classification of pleural effusions. Clin Chem 2003; 49: 740-5.
12. Choi KW, Chau TN, Tsang O et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med 2003; 139: 715-23.
13. Chan JWM, Ng CK, Chan YH et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 2003; 58: 686-9.
14. Lott JA, Nemesánszky E. Lactate dehydrogenase. In: Lott JA, Wolf PL, eds. Clinical Enzymology: A Case-orientated Approach. New York: Field, Rich and Associates, Inc., 1986; 227-9.
15. Onigbinde TA, Wu AH, Johnson M et al. Clinical evaluation of an automated chemical inhibition assay for lactate dehydrogenase isoenzyme 1. Clin Chem 1990; 36: 1819-22.
16. Tsui PT, Kwok ML, Yuen H et al. Severe acute respiratory syndrome: clinical outcomes and prognostic correlates. Emerg Infect Dis 2003; 9: 1064-9.
17. Wong CK, Lam CWK, Wu AKL et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 2004; 136: 95-103.
18. Yuen KY, Chan PKS, Peins M et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351: 467-71.
19. Rimmelzwaan GF, Kuiken T, van Amerongen G et al. Pathogenesis of influenza A (H5N1) virus infection in a primate model. J Virol 2001; 75: 6681-91.
20. Tumpey TM, Lu X, Morken T et al. Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J Virol 2000; 74: 6105-16.
21. De Franceschi L, Fattovich G, Turrini F et al. Haemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hepatology 2000; 31: 997-1004.
22. Centers for Disease Control and Prevention. Severe acute respiratory syndrome (SARS) - Is the use of ribavirin (or other antiviral drugs) effective in the treatment of patients with SARS? http://www.cdc.gov/ncidod/sars/qa/ illness.htm (accessed 24 May 2003).
23. Knowles SR, Phillips EJ, Dresser L et al. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. Clin Infect Dis 2003; 37: 1139-42.
24. Wong RSM, Wu A, To KF et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 2003; 326: 1358-62.
25. + T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. http://www.cdc.gov/mmwr/ preview/ mmwrhtml/rr5202a1.htm (accessed 24 May 2003).
26. Lapinsky SE, Hawryluck L. ICU management of severe acute respiratory syndrome. Intensive Care Med 2003; 29: 870-5.
27. Hannet I, Erkeller-Yuksel F, Lydyard P et al. Developmental and maturational changes in human blood lymphocyte populations. Immunol Today 1992; 13: 215-8.